Polyclonal Antibodies
Anti-DOCK7 Polyclonal Antibody for WB, ELISA - Q96N67
Item Number : CM0019599
Price varies based on specs and customizations
- Application
- WB, ELISA
- Cross Reactivity
- Human, Mouse, Rat
- Protein Weight
- 243kDa
Shipping:
Contact us to get shipping details Enjoy On-time Dispatch Guarantee.
Why Choose Us
Easy ordering process, quality products, and dedicated support for your business success.
Core Product Specifications and Parameters
| Parameter | Value |
|---|---|
| Product Name | DOCK7 Rabbit pAb |
| Remarks/Alias | ZIR2; DEE23; EIEE23; DOCK7 |
| Species | Human |
| GeneID (Human) | 85440 |
| GeneID | 85440 |
| Immunogen | A synthetic peptide corresponding to a sequence within amino acids 100-200 of human DOCK7 (NP_001354490.1). |
| Source | Rabbit |
| Category | Polyclonal Antibodies |
| Application | WB, ELISA |
| Cross Reactivity | Human, Mouse, Rat |
| SWISS | Q96N67 |
| Protein Weight | 243kDa |
| Shipping | Ice bag |
Biological Background: DOCK7 Function and Localization
- DOCK7 functions as a guanine nucleotide exchange factor (GEF) for Rac1 and Rac3, promoting GDP/GTP exchange; it shows no activity toward CDC42.
- During axon formation, DOCK7 is required for STMN1 phosphorylation at Ser-15, which is critical for neuronal polarization. Related references: PMID:16982419
- As a component of the DISP complex, DOCK7 may regulate septin-actin interactions, thus modulating the actin cytoskeleton. Related references: PMID:29467281
- DOCK7 plays a role in pigmentation, as suggested by similarity to related proteins.
- In cortical development, DOCK7 regulates the proliferation versus differentiation of radial glial cells by negatively regulating TACC3-mediated microtubule growth, controlling interkinetic nuclear migration.
- Subcellularly, DOCK7 localizes to cell projections, particularly axons.
- It is widely expressed across tissues and is subject to multiple post-translational modifications including acetylation, methylation, and phosphorylation.
- DOCK7 is associated with developmental processes, neurogenesis, and epilepsy; alternatively spliced isoforms exist.
Experimental Guidance and Technical Tips
- The immunogen is a synthetic peptide spanning residues 100–200 of human DOCK7 (isoform NP_001354490.1); this region may be conserved across isoforms, potentially allowing recognition of multiple variants.
- For western blotting (WB), the predicted molecular weight of DOCK7 is approximately 243 kDa. Use an appropriate low-percentage SDS-PAGE gel and extended transfer times to ensure efficient detection of such a large protein.
- In ELISA applications, consider using recombinant DOCK7 protein or peptide antigens to validate antibody specificity; direct or indirect ELISA formats can be employed.
- This antibody is documented to cross-react with human, mouse, and rat samples, as indicated by the supplier, but end users should verify reactivity in their specific experimental systems.
CamelBio: Your One-Stop Sourcing Bridge
CamelBio provides diagnostic manufacturers and research laboratories with a comprehensive, one-stop platform for IVD raw materials, including validated antibodies, recombinant proteins, and ancillary reagents. For DOCK7-related research in neuronal polarization, cytoskeletal dynamics, and neurodevelopmental disorders, we offer reliable sourcing for anti-DOCK7 polyclonal antibodies like this product, as well as custom development of matched antibody pairs and bulk reagent supply to accelerate your assay development from concept to clinic.
Product Datasheet
Anti-DOCK7 Polyclonal Antibody for WB, ELISA - Q96N67
REQUEST A QUOTE
Our professional team will reply to you within one business day. Please feel free to contact us!